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Abstract
Knowledge of the three-dimensional (3D) architecture of blood vessels in the brain is crucial because the progression of
various neuropathologies ranging from Alzheimer’s disease to brain tumors involves anomalous blood vessels. The
challenges in obtaining such data from patients, in conjunction with development of mouse models of neuropathology,
have made the murine brain indispensable for investigating disease induced neurovascular changes. Here we describe a
novel method for ‘‘whole brain’’ 3D mapping of murine neurovasculature using magnetic resonance microscopy (mMRI).
This approach preserves the vascular and white matter tract architecture, and can be combined with complementary MRI
contrast mechanisms such as diffusion tensor imaging (DTI) to examine the interplay between the vasculature and white
matter reorganization that often characterizes neuropathologies. Following validation with micro computed tomography
(mCT) and optical microscopy, we demonstrate the utility of this method by: (i) combined 3D imaging of angiogenesis and
white matter reorganization in both, invasive and non-invasive brain tumor models; (ii) characterizing the morphological
heterogeneity of the vascular phenotype in the murine brain; and (iii) conducting ‘‘multi-scale’’ imaging of brain tumor
angiogenesis, wherein we directly compared in vivo MRI blood volume measurements with ex vivo vasculature data.
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Introduction
The neurovasculature plays a critical role in a wide range of
neuropathological processes from dementia to stroke to tumors
[1]. In addition, the physiological underpinnings of image contrast
in functional MRI (fMRI) critically involves the neurovasculature
[2], and is central to understanding drug delivery and pharma-
cokinetics of novel therapies in the brain [3,4]. The challenges in
obtaining high-resolution vascular data from patients, combined
with new pre-clinical models of neuropathology, have made the
mouse brain indispensable to investigations of these areas [5,6].
Historically, high-resolution characterization of the murine
neurovascular architecture has involved either two-dimensional
(2D) measurements made on tissue sections from 3D specimens [7]
or three-dimensional (3D) measurements made on corrosion casts
[8]. Although 3D reconstruction of 2D tissue slices generates high
resolution imaging data, the practical limit as to the number of
adjacent tissue slices that can be obtained limits the region of brain
that can be interrogated. Additionally, recovering the 3D blood
vessel and white matter fiber geometry once destroyed by tissue
sectioning requires complex reconstruction techniques. Conversely,
corrosion casts allow extensive brain regions to be analyzed but
require dissolving of tissues to visualize cast vessels, and thus
precludes simultaneous assessment of the vasculature and neuro-
anatomy.
Recent advances in imaging technology have permitted the
visualization of the murine neuroarchitecture in exquisite detail
using magnetic resonance microscopy (mMRI), a type of 3D MRI
that offers high ex vivo imaging resolutions (currently ,20–30 mm
3)
[9]. Using mMRI one can obtain images with different kinds of
‘‘physiological stains’’ or image contrast mechanisms, e.g. diffusion
tensor imaging (DTI) to visualize the orientations of white matter
fibers in the brain [10].
Studies describing wide-area-mapping of the murine brain
vasculature with 3D mMRI have been limited due to the difficulties
associated with sample preparation, contrast mechanism employed,
image co-registration, and image processing for vessel extraction.
For example, Dorr et al combined vascular data obtained using
micro computed tomography (mCT) with a mMRI murine brain
atlas. While this approach exploits the strengths of each modality,
co-registration of these 3D image volumes is challenging [11]. This
is especially true when it involves registration with DTI or the
abnormal vasculature of brain tumors. Gelatin doped with
gadolinium chelates has also been employed to image both, mouse
embryo [12] and adult rat brain [13] vasculature using mMRI.
Unfortunately, the use of gelatin perfusate is not ideal as it needs to
be mixed with high concentrations of gadolinium chelate to achieve
sufficient T1 relaxation, and diffusion of these chelates out of the
blood vessels over time results in loss of vascular contrast. Here we
describe a new method for extending the utility of 3D mMRI to
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the abovementioned drawbacks. We validated our vascular mMRI
technique using optical and mCT techniques and present three
important biological applications to demonstrate the utility of this
approach for characterizing changes in the neurovascular micro-
environment wrought by invasive and non-invasive pre-clinical
brain tumor models.
To circumvent the limitations of traditional vascular imaging
approaches, we perfused murine brains with an inert silicone rubber
compound (MICROFILH, FlowTech Inc., MA) which has a low
viscosity that permits complete filling of the murine cerebral
vasculature [14]. Following polymerization, Microfilled blood
vessels appear dark on gradient-echo MRI images due to the
absence of mobile water and potential susceptibility contrast. Being
hydrophobic restricts the MicrofilH to the vasculature with minimal
extravasation. Additionally, because MicrofilH is radio-opaque and
light microscopy opaque, it enables validation of the mMRI-derived
vascular data with mCT, x-ray imaging and bright field whole
mount microscopy as we have demonstrated in this study.
We demonstrate the potential of our mMRI technique via
several applications that include combined 3D imaging of
angiogenesis-induced vascular remodeling and white matter
reorganization in both, invasive and non-invasive brain tumor
models; characterization of the morphological heterogeneity of the
neurovasculature; and ‘‘multi-scale’’ imaging of brain tumor
angiogenesis. Since mMRI generates digitized 3D images, the
neurovascular data derived from it can be employed in a plethora
of applications ranging from the study of cerebral hemodynamics
[15] to image contrast mechanisms in MRI [16].
Results
Validation of mMRI-derived brain vasculature with mCT
OneoftheprincipleideasunderlyingvascularmMRIistoacquire
a 3D representation of the murine cerebral vasculature at high
spatial resolution while achieving ‘‘whole brain’’ spatial coverage.
Brains were perfused with the silicone rubber compound MicrofilH
that is both, optically (Fig. 1a) and x-ray (Fig. 1b) opaque. The
difference in magnetic susceptibility between the Microfilled vessels
and surrounding cerebral tissue enhances the gradient-echo
relaxation rate at the vessel boundaries as shown in Fig. 1c.
Additionally, the vessel lumen appears dark due to the lack of
mobile protons within the polymerized MicrofilH. We validated the
fidelity of the mMRI-derived vasculature by comparing it to that
acquired using mCT and whole-mountopticalmicroscopy. Thiswas
achieved by imaging the same brain sample using all three
modalities. Fig. 1d demonstrates that there was excellent overlap
between the co-registered mMRI and mCT-derived vasculatures.
Additionally, bright field microscopy of a whole-mount brain
section confirmed that the mMRI-visible features were MicrofilH-
bearing vessels (Fig. 1e). Finally, we confirmed the high quality of
the mMRI data by assessing the correlation between the fractional
blood volume (FV) computed from mMRI with that computed from
mCT. We found that in spite of being computed from two different
imaging modalities, there was strong correlation between FV values
for both, a 1 mm thick brain slice (Fig. 1f), as well as over the entire
brain sample (Fig. 1g). These data establish the fidelity of the
mMRI-derived vasculature.
Simultaneous visualization of brain tumor angiogenesis
and invasion
A principal advantage of vascular mMRI is the ability to combine
3D cerebral vasculature data with co-registered MRI data acquired
using a range of complementary contrast mechanisms. Fig. 2
illustrates the power of this approach for illuminating changes in the
neuroarchitecture that accompany angiogenesis in an orthotopic,
invasive human brain tumor model. For instance, the fractional
anisotropy (FA) map (Fig. 2a), a scalar measure of the degree of
anisotropy in a given imaging voxel, shows a dark area in the corpus
callosum (Fig. 2b) in which the FA is lower than that of adjacent
white matter (Fig. 2c). The histology (Fig. 2d) demonstrates that
this lowering of FA correlates with invasion of the white matter tract
by infiltrating brain tumor cells. Another method of visualizing
changes in the neuroarchitecture is illustrated in (Fig. 2e). Here the
tensor that describes the 3D shape of diffusion is represented as 3D
ellipsoid glyphs inwhich eachellipsoid isscaledaccordingthevalues
of the three principal eigen-vectors, and color coded according to
the FA. The invasive primary tumor is easily identifiable by its low
FA in contrast to the contralateralbrain. The 3D vasculature for the
whole brain is shown in (Fig. 2f) in which the dense, chaotic tumor
vasculature is obvious relative to the regular, hierarchical
vasculature of the contralateral brain. Finally, the interaction
between brain tumor angiogenesis and the effects of tumor invasion
on the integrity of white matter tracts can be simultaneously
visualized by combining these 3D data as shown in (Fig. 2g).
Therefore, an added advantage of using Microfil as an MRI
contrast agent is that its presence does not have any deleterious
effects on diffusion-weighted MRI contrast.
Zonal analysis of mMRI-derived vasculature
The extensive spatial coverage of 3D mMRI permits one to
sample the spatial heterogeneity of the underlying vascular
phenotype.For example,itiswellknownthat the vesselmorphology
of the angiogenic brain tumor is drastically different from that of the
contralateral brain. Here we explicitly demonstrate the feasibility of
characterizing differences in vessel segment length and radius in
three different zones using ‘‘ultra-high’’ resolution mMRI (Fig. 3a).
In addition to the tumor and normal zones, we defined a transition zone
that straddles the tumor-brain tissue interface. We found that the
normalzone hadsignificantlylonger vesselsegments compare to the
transition (p=0.002) and tumor zones (p,0.001), and that vessel
radiiwereheterogeneouslydistributedforthistumorstage(Fig.3b).
Ultra-high resolution mMRI permits the simultaneous assessment of
vascularization and white matter reorganization in the presence of a
non-invasive (9L) brain tumor model (Fig. 3c–f). In contrast to
white matter tract infiltration seen in the invasive brain tumor
model, the non-invasive 9L brain tumor simply displaces the
surrounding white matter tracts (Fig. 3e).
Multi-scale imaging of brain tumor angiogenesis
The emergence of systems-biology approaches has necessitated
the acquisition of ‘‘multi-scale’’ data to bridge the gap between
various components of the biological system being studied [17].
Such data can be acquired using imaging methods and then be
either incorporated into mathematical models or used to validate
such models. Here we illustrate one instance of imaging
angiogenesis in a 9L brain tumor bearing mouse brain at two
spatial scales using entirely unique contrast mechanisms: in vivo
using susceptibility-contrast arising from the superparamagnetic
contrast agent Feridex (Fig. 4a), and ex vivo using contrast arising
from the lack of free water protons in the Microfilled blood vessels
(Fig. 4b). The former provides a map of the change in the
gradient-echo relaxation rate (DR2*) which is reflective of the
macrovascular or total cerebral blood volume (Fig. 4a), while the
latter is the fractional volume (FV) map computed directly from
the mMRI-derived vasculature (Fig. 4b). One can see that both,
the in vivo MRI and ex vivo mMRI exhibit identical trends in blood
volume, i.e., the tumor blood volume is elevated with respect to
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(Fig. 4e) reiterates the trend in the blood volume measured using
these independent methods and illustrates the correlation between
them. Fig. 5 illustrates the range of spatial resolutions that one can
span, with in vivo MRI at one end, and ultra-high resolution mMRI
at the other end of the spatial resolution spectrum.
Discussion
Traditionally, the neurovasculature in murine models of disease
has been characterized at two spatial scales: the ‘‘cellular’’ or
microscopic scale using 3D optical techniques [18,19], and the
‘‘systemic’’ or macroscopic scale using methods such as contrast
Figure 1. 3D imaging of the murine neurovasculature with mMRI and validation with mCT and optical microscopy. (a) Photograph of a
freshly excised mouse brain showing blue MicrofilH perfused vessels (arrows). (b) X-ray radiograph of the same brain in which radio-opaque
microfilled vessels are clearly visible. Arrows indicate major vessels that are also visible in (a). (c) Slice through the 3D R2* map of the same brain. The
Microfil-brain tissue interface is characterized by elevated R2* (hot colors) values. Note that background voxels are assigned R2* of zero. (d) ,1.2 mm
slab from another intact brain, in which mMRI-derived vasculature (gold) is overlaid on that acquired using mCT (purple). One can clearly visualize the
vascular architecture and the agreement between mMRI and mCT. (e) Bright-field images (26) of ROIs corresponding to colored squares in (d). Images
are from a 1 mm thick, unstained brain section. Dark microfilled vessels provide corroboration of the mMRI data in (d). Arrows indicate major vessels
that are also visible in (d). mCT data were resampled to match the mMRI spatial resolution, and the fractional vascular volume (FV) computed within
86861 subvolumes for each dataset. The correlation between the mMRI and mCT-derived FVs for the 1 mm thick slice is plotted in (f). A similar
analysis was conducted for the whole brain, wherein the FV was computed within 86868 subvolumes for each dataset. The correlation between the
mMRI and mCT-derived FVs for the whole brain is plotted in (g) and demonstrate good agreement between mMRI and mCT-derived vasculature. The red
lines in (f) and (g) are the best linear fit to the data, and blue lines indicate the 95% confidence limits about the mean.
doi:10.1371/journal.pone.0022643.g001
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or computed tomography (CT) [11,22] [17]. Optical approaches
suffer from limited tissue penetration and provide relatively small
fields of view. This makes ‘‘whole brain’’ coverage and co-
registration with in vivo imaging data from complementary imaging
modalities challenging. Conversely, mCT provides unparalleled 3D
detail, but has limited soft tissue contrast (e.g. gray and white
matter contrast), which is crucial to any comprehensive study of the
neurovasculature. ‘‘Mesoscopic’’ resolution (20–40 mm) vascular
mMRI bridges the gap between these spatial scales and enables
imaging of the entire brain vasculature while simultaneously
providing outstanding gray and white matter contrast.
While newer methods such as volumetric computed tomogra-
phy (VCT) [23] and synchrotron tomography [24] are capable of
vascular imaging at exquisite spatial resolutions, they lack soft
tissue contrast and require specialized detectors and a high-energy
synchrotron source, respectively. Compared to these methods,
vascular mMRI has three major advantages. First, it does not
require specialized MRI hardware, and is inexpensive and easy to
implement on any mMRI scanner. Second, it provides exception-
ally high quality, 3D images of the vasculature by exploiting a
novel contrast mechanism that can be easily combined with other
MRI contrast mechanism (e.g., DTI) without affecting their
quality. Third, it yields stable samples that can be imaged non-
destructively with MRI, CT or optical microscopy without
requiring any additional contrast agents or labels.
A current limitation of using mMRI to image the vasculature of
the whole mouse brain is that even at ,30 mm resolution,
arterioles, venules and capillary-sized vessels are undetectable.
This difference is apparent when comparing the vascular coverage
visible in mMRI (Fig. 1d) and that visible in mCT (Fig. 1d) and
histology (Fig. 1e). This constraint on the mMRI spatial resolution
results in partial volume effects that impact the calculation of
morphological vascular parameters. For example, partial volume
effects can lead to overestimations of vessel length, caliber and
fractional volume, and an underestimation of vessel tortuosity.
With the availability of higher magnetic field imaging systems
(9.4 Tesla or higher) and more powerful imaging gradients, it will
be possible to acquire higher spatial resolution mMRI images.
However, this improvement in resolution will come at the expense
of increased image acquisition times, which will result in large size
image data sets and limit the number of samples that can be
imaged. While strategies such as doping the sample with
gadolinium to shorten the tissue T1 or employing partial Fourier
reconstruction schemes ameliorates protracted imaging times [25],
achieving reasonably high signal-to-noise ratio (SNR) with smaller
voxel sizes remains a technical challenge. This is further
compounded by the fact that Microfilled vessels contain a limited
amount of mobile ‘‘MR visible’’ water.
Both, excision from the skull and tissue fixation result in
distortion of the brain tissue. For mMRI, the brain sample is
enclosed in a 10mm glass NMR tube and for mCT the sample is
embedded in a gel prior to imaging. Each of these steps also
induce tissue distortions. Collectively, these tissue distortions
preclude direct vessel-to-vessel co-registration between the mMRI
and mCT data at their native spatial resolution. For example, at
the ,60 mm resolution of mMRI, misalignments of the order of a
few mMRI voxels between the mMRI and mCT-derived vascula-
Figure 2. Simultaneous imaging of brain tumor angiogenesis and invasion with mMRI. (a) FA map of a patient-derived, invasive primary
glioma model. (b) Zoomed view of the hatched region in (a) showing two ROIs in the corpus callosum for which the FA was analyzed. (c) Histograms
of the FA from the ROIs in (b), wherein one can see that the FAs from ROI-1 are shifted toward lower values than those from ROI-2. (d) Histology (H&E)
from the same region as in (b) in which one can see the white matter tract (WM) being infiltrated by a tuft of tumor cells (I). The tumor margin (T) is
also visible in (d). (e) Visualization of the DTI tensors as 3D ellipsoid glyphs for one mMRI slice, wherein each ellipsoid is scaled according the values of
the three principal eigen-vectors and color coded according to the FA. The invasive primary tumor (hatched outline) is identifiable by its lower FA in
contrast to the contralateral brain. (f) Visualization of the 3D vasculature for the whole brain. Tumor vasculature (hatched outline) is dense and
chaotic relative to that of the contralateral brain. (g) The image in (e) overlaid with that in (f) allows us to simultaneously assess the interaction
between brain tumor angiogenesis and the effects of tumor invasion on the integrity of white matter tracts. The tumor ROI is highlighted by a
hatched outline.
doi:10.1371/journal.pone.0022643.g002
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fore, to validate the vascular coverage of the mMRI data with that
derived from mCT, we computed the fractional blood volume (FV)
for both datasets on a coarse spatial grid. We selected the FV as it
is a morphological parameter that is function of both, vessel caliber
and vessel density [26]. To ensure insensitivity to misalignments
between the two datasets, we computed the FV by calculating the
fractional occupancy of the binarized vasculature derived from the
mMRI and mCT data within a coarse 86868 spatial grid and
found good agreement between the FVs obtained from the two
methods. Due to the variety of measurement techniques
employed, reported values for the blood volume in the mouse
brain range from ,0.5%–6% [22,27,28,29,30]. The FV of 3.2%
computed from the mCT data fall within this range, while the FV
of 7.9% computed from the mMRI data overestimates the FV due
to partial volume effects. Although mMRI does not have the ability
to resolve cortical capillaries, it is capable of ‘‘wide-area’’ or
‘‘whole brain’’ mapping of the neurovasculature. While it does
offer superior coverage compared to most optical techniques,
mMRI cannot outperform mCT in terms of spatial resolution. The
advantage of mMRI is that one can employ complementary
contrast mechanisms such as DTI, to simultaneously measure
changes in the brain’s microenvironment.
Recent evidence has emerged that antiangiogenic therapy in
brain tumors promotes an invasive phenotype [31,32]. This has
created an urgent need for noninvasive methods to characterize
the angiogenesis-invasion nexus and the efficacy of combined
antiangiogenic/anti-invasive therapies in brain tumor models.
Here, we demonstrated the feasibility of imaging changes in the
whole brain microenvironment induced by both, invasive and
non-invasive brain tumor models. While others have characterized
brain tumor induced alterations in the brain’s cytoarchitecture
Figure 3. Ultra-high resolution 3D mMRI and ‘‘zonal’’ analyses of the neurovasculature. (a) 3D rendering of the neurovasculature in a non-
invasive, 9L tumor bearing mouse brain acquired using ultra-high resolution (30 mm630 mm630 mm) mMRI. The vasculature has been color coded
into three different ‘‘zones’’: normal vessels (blue), tumor vessels (red) and vessels at the tumor-brain interface or transition zone (green). The
transition-zone or tumor-brain tissue interface is crucial to understanding both, brain tumor angiogenesis and invasion. The radius and length of
every individual vessel segment was measured in each zone. (b) Box plot of the average vessel length in each zone, wherein the width of each box
includes 75% of the measured lengths and the median length is indicated by a horizontal line in each box. In addition, the radius of every vessel
segment is plotted for each zone, with the color and size of each symbol proportional to the vessel radius. The normal zone exhibited significantly
longer vessel segments compare to the transition (p=0.002) and tumor zones (p,0.001), respectively. At this tumor stage, vessel radii were similar
between the tumor and normal zones. These data demonstrate our ability to characterize the neurovasculature in physiologically relevant ‘‘zones’’,
and could provide new insight into the relationship between brain tumor angiogenesis and invasion. (c) T2-weighted mMRI slice through a 9L brain
tumor (gold rendering) bearing brain. (d) 3D overlay of the neurovasculature acquired using ultra-high resolution mMRI. (e) 3D DTI image showing
reorganization of the fibers of the anterior commissure (ac) and internal capsule (ic) around the tumor. (f) Overlay of (d) and (e) illustrating
simultaneous changes in vascular and white matter structures.
doi:10.1371/journal.pone.0022643.g003
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vasculature has not been reported. It is this ability of mMRI to
simultaneously visualize brain tumor vascularization and white
matter remodeling over the entire murine brain that makes it a
powerful new tool for understanding the interplay between
angiogenesis and invasion in pre-clinical brain tumor models. In
a recent study, we successfully demonstrated the ability of mMRI
to phenotype global and zonal changes in the brain tumor
microenvironment with tumor progression [34].
The evolution in our understanding of brain tumor angiogenesis
has been the result of pioneering studies spanning the endothelial
cell [35], microvasculature [36] and tissue level [37]. Many of
these primary data on angiogenesis are in the form of images from
pre-clinical models that provide a wealth of qualitative and
quantitative information in many dimensions, and across different
spatial scales. However, simultaneously visualizing changes in the
complex angiogenic microenvironment at different spatial scales
remains a challenge due to the lack of integration between micro-
and macroscopic imaging data and the difficulty in obtaining such
data from patients. Therefore, ‘‘mesoscopic’’ mMRI could be an
expedient tool for integrating micro- and macroscopic angiogen-
esis imaging data. Here, we showed an example in which co-
registered FV maps computed from ex vivo mMRI data were
employed to validate in vivo macroscopic blood volume measure-
ments. This imaging platform could easily be extended to establish
a toolbox for integrating multi-scale data on brain tumor
angiogenesis.
Our approach for mMRI imaging of the neurovasculature has
several widespread applications: integration with extant MRI
brain atlases, incorporation in biophysical models of MR contrast
Figure 4. Bridging macroscale and microscale MRI. (a) In vivo macrovascular CBV (DR2*) map. (b) Co-registered ex vivo fractional blood volume
(FV) map obtained from mMRI. The tumor ROI is highlighted by hatched lines in each panel and FV ranges from 0 to 1. (c) Histograms showing the
relative distribution of the DR2* between tumor and contralateral ROIs. (d) Histograms showing the relative distribution of the FV between tumor and
contralateral ROIs. Tumor blood volume is elevated relative to the contralateral brain across these ‘‘multi-scale’’ data. (e) 2D histograms of the
macrovascular CBV measured in vivo versus the fractional blood volume assessed ex vivo. These data further demonstrate the utility of multi-scale
imaging of brain tumor vascularization.
doi:10.1371/journal.pone.0022643.g004
Figure 5. Multi-scale MRI of a 9L brain tumor model. (a) In vivo T2-weighted MRI at the ‘systemic’ scale (,150 mm); ex vivo mMRI at two
‘intermediate’ scales: (b) ,60 mm, and (c) ,30 mm. (d) Ultra-high resolution vascular mMRI image in which vessels have been segmented into tumor
vessels (gold) and normal vessels (red). One can clearly visualize the abnormal tumor vessel architecture and changes in vessel morphology at the
tumor-host tissue interface (arrows).
doi:10.1371/journal.pone.0022643.g005
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protein data from immunohistochemistry, fluid dynamic simula-
tions of tumor blood flow, multi-scale mathematical models of
angiogenesis, and phenotyping pathological samples. The advan-
tages and ease-of-implementation of vascular mMRI make it an
indispensable tool for the study of neuropathologies that involve an
aberrant neurovasculature.
Methods
Ethics Statement
All animals were handled in accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was conducted under a
protocol (#MO07M287) approved by the Institutional Animal
Care and Use Committee (IACUC) of Johns Hopkins University.
The Johns Hopkins University animal facility is accredited by the
American Association for the Accreditation of Laboratory Animal
Care and meets National Institute of Health standards as set forth
in the ‘‘Guide for the Care and Use of Laboratory Animals’’
(DHHS Publication No. (NIH) 85–23, Revised 1985).
In Vivo MRI Protocol
9L and human primary brain tumor derived cells were
orthotopically inoculated according to the protocol described in
[26]. 9L brain tumor bearing animals were imaged in vivo on a
400 MHz Bruker spectrometer using the following sequences and
parameters: (i) T2*-weighted (T2*w) multi-echo gradient echo
(MGE), eight echoes, first TE=5.0 ms, echo spacing=5.0 ms,
TR=800 ms, NA=12. (ii) T2w rapid acquisition with refocused
echoes (RARE), six echoes, first TE=12.0 ms, echo spa-
cing=12.0 ms, TR=2000 ms, NA=4. For all scans: in-plane
resolution=0.1 mm60.1 mm, 16 coronal slices, slice thick-
ness=1 mm. Animals were imaged under isoflurane anesthesia,
with their body temperature maintained at 37uC using a heating
blanket. Images were acquired before and after equilibration of the
superparamagnetic MRI contrast agent Feridex (AMAG Pharma-
ceuticals, Inc., Cambridge, MA), administered at a dose of
3.73mg/ml of Fe via a tail vein cannula. Pre- and post-contrast R2
(i.e. 1/T2) and R2* (i.e. 1/T2*) maps were calculated from the in
vivo T2w and T2*w images, respectively.
Sample Preparation for ex vivo mMRI and mCT imaging
9L and primary brain tumor-bearing animals were sacrificed
approximately two and five weeks post-inoculation, respectively.
Brains were perfusion fixed, followed by perfusion with a silicone
rubber compound called MicrofilH (FlowTech Inc., MA) according
to a method wepreviously developed [38]. Briefly,miceweredeeply
anesthetizedwith isofluranethen perfused viatheleftventricle–first
withheparinized PBS, then with10%buffered formalinfor fixation,
and finally with a 1:2 mixture of MicrofilH to diluent and 5% (v/v)
curing agent. The MicrofilH was allowed to cure at room
temperature for 90 minutes, and then the heads were fixed in cold
paraformaldehyde (PFA) for two days. Next, brains were excised
from their skulls and stored in cold PFA. Twenty-four hours prior to
imaging, each brain was immersed in PBS doped with 1 mM Gd-
DTPA (GE Healthcare) to enhance soft tissue contrast. Each brain
was imaged in an NMR tube filled with FomblinH (Solvay Solexis,
Milano, Italy), whichprovides a dark, uniformimage background as
it does not contribute any proton signal to the MR images.
Magnetic Resonance Microscopy Protocol
Post-fixation, brain were imaged on a 400 MHz spectrometer
using the following sequences and parameters: (i) T2*-weighted
(T2*w) multi-echo gradient echo (MGE), FOV=16mm610mm6
8mm, TE=4.9/9.7/14.5/19.3 ms, TR=150 ms, resolution=
62 mm662 mm663 mm, 14 averages. (ii) T2w rapid acquisition
with refocused echoes (RARE), TE/TR=63.4/2500 ms, resolu-
tion=102 mm6102 mm6101 mm, 4 averages. (iii) Diffusion tensor
imaging (DTI), TE/TR=26.8/2000 ms, resolution=94 mm6
97 mm6600 mm, 6 averages; one non-diffusion weighted image
and six diffusion weighted (DW) images were acquired with a
b-value of 1700 s/mm
2 and diffusion sensitizing gradient orien-
tations: [1,1,0], [1,0,1], [0,1,1], [21,1,0], [1, 0, 21], [0, 21, 1].
To enable zonal analysis of the vascular morphology, ultra-high
resolution MGE mMRI data were acquired with a resolu-
tion=33 mm631 mm630 mm. Along with the ultrahigh-resolution
vascular mMRI, we also acquired co-registered DWI with a
resolution=66 mm652 mm644 mm, b-value=1500 s/mm
2 and
the same diffusion sensitizing gradient orientations as before.
Micro Computed Tomography Protocol
Samples were sent to Numira Biosciences (Salt Lake City, UT)
and were imaged on a high-resolution, volumetric micro-CT
scanner (mCT40, ScanCo Medical, Zurich, CH). The image data
was acquired with the following parameters: 8 mm isotropic voxel
resolution at 55 kVp 300 ms exposure time, 2000 views and 5
frames per view. The mCT generated DICOM files were then
converted to a .raw file format for additional analysis.
Image Processing
Calculation of in vivo relative blood volume maps. Pre-
and post-contrast R2 (i.e. 1/T2) and R2* (i.e. 1/T2*) maps were
calculated from the in vivo T2w and T2*w images, respectively, via
voxel-wise monoexponential fitting of the intensity vs. time curves:
ST E i ðÞ ~S0 exp{R2   ðÞ TEi , i~1, ..., # of echoes ð1Þ
Where S(TEi) is the measured signal intensity at the i
th TE and S0
is the signal intensity at t=0. The following constraints were
imposed during curve-fitting: 0,S0,2
16 (16-bit data) and
0,R2
(*
),1( T 2.1 ms). Finally, the macrovascular or total (i.e.
DR2*) cerebral blood volume maps were calculated:
DR2
  ðÞ ~R2
  ðÞ
post{R2
  ðÞ
pre ð2Þ
The background of the R2*map was masked out and each
background voxel assigned an R2* of zero. All images were
processed using Analysis of Functional NeuroImages (AFNI)
software [39].
Vessel segmentation. 3D MGE images corresponding to
the first TE, which have the highest SNR (signal-to-noise-ratio)
and the least susceptibility related artifacts, were imported into
ImageJ (Rasband, W.S., National Institutes of Health, Bethesda,
Maryland, USA, http://rsb.info.nih.gov/ij/) for blood vessel
extraction and computation of vascular morphological parame-
ters. The image processing procedure for vessel extrac-
tion is summarized in Fig. 6. Briefly, the vasculature was
automatically segmented from the brain using a Hessian-based,
multi-scale ‘‘tubeness’’ filter [40]. This filter determines how
‘‘tube-like’’ a voxel is by convolving the image with a spherical
Gaussian kernel with standard deviation s, computing the Hessian
matrix at each voxel, and computing a ‘‘tubeness’’ metric from the
Hessian eigenvalues. The sensitivity of the ‘‘tubeness’’ filter to
tubular structures of varying radii can be tuned by varying s.
Therefore, we implemented a multi-scale integration of filter
responses using three s values (s=0.8, 1.0, 1.2) to optimally
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3D vascular structure was obtained by applying an iterative
threshold algorithm [41] on the result of the ‘‘tubeness’’ filter. To
eliminate small, disconnected objects and gaps in the vasculature,
the binary image was subjected to a 3D size filter to remove
isolated background and foreground regions smaller than three
voxels.
A similar method was used to extract the vessels from the mCT
data. Because of the higher spatial resolution, a wider range of s
values (s=1.5
n, n=0, 1,…,5) was used for the ‘‘tubeness’’ filter,
and a threshold of 27 voxels was used for the 3D size filter.
Validation of mMRI with mCT and optical imaging. We
validated the mMRI-derived vasculature with the mCT-derived
vasculature. To do this, we used landmark-based registration to
manually co-register the mMRI and mCT-derived whole brain
vasculature in Amira (Visage Imaging Inc., CA). We then
extracted ,1mm-thick slabs from the whole brain mMRI and
mCT data and subjected them to another landmark-based
registration to refine the co-registration between them. For all
the co-registrations, landmarks were placed on large vessel
bifurcations visible in both datasets, and aligned using the thin-
plate spline method [42]. The mCT data was then resampled to
the mMRI resolution in AFNI to approximate the vascular
structure that would be obtained from mMRI given the mCT
vasculature as the ground truth. For both, mMRI and mCT
datasets we calculated the fractional occupancies of vessels in an
86868 (voxel size=2mm61.25mm61mm) grid for the whole
brain and an 86861 grid for the 1mm-thick slab using AFNI.
Voxel-wise correlations of the fractional blood volume maps were
then computed between these two datasets. Finally, the mMRI and
mCT data were also validated with optical microscopy by visual
inspection. The 1 mm-thick slab used in the mMRI vs. mCT
correlation analysis was excised and the tissue cleared by graded
immersion in glycerin. The tissue was first immersed in a mixture
of 50% glycerin and water, and every 24 hours, the glycerin
concentration was sequentially increased to 75%, 85%, and 100%.
After clearing, the brain tissue slab was mounted on a microscope
slide, and a bright field image acquired at 26magnification.
Characterization of vascular morphology. After seg-
menting the vasculature, we computed several morphometric
parameters to characterize the 3D vascular architecture. The
fractional vascular volume (FV) of the tumor and CL regions of interest
(ROIs) was determined by computing the fractional occupancy of
the binary vascular structure within each ROI. The ImageJ ‘‘3D
Skeletonization’’ plugin was used to automatically extract the
vascular centerlines or 3D skeleton [43] and compute vessel branch
lengths. To measure vessel radius, a 3D Euclidean distance map [29] of
the vasculature was computed using the ChamferMap module in
Amira. This EDM represents the smallest distance between each
vessel voxel and the background. Vessel radii were determined by
multiplying the binary skeletonized image with the EDM.
Zonal analysis. A transition zone at the tumor-brain tissue
interface approximately 200 mm wide was identified by histology
based on cell density and vascular morphology. This transition
zone was defined in the mMRI data from the manually drawn 3D
tumor ROI. We applied 3D morphological dilation and erosion
operations using a spherical structuring element (,100 mm
diameter) on the tumor ROI. The eroded ROI was subtracted
from the dilated ROI to obtain the transition zone. The
morphological parameters described above were calculated for
the tumor ROI, transition zone and normal brain.
Comparison of in vivo and ex vivo MRI blood volume
measurements. The ex vivo MRI data was co-registered to the
in vivo MRI to compare the blood volume measurements obtained
from the two techniques. The high-resolution 3D ex vivo MGE data
was resampled in Amira (Visage Imaging Inc., CA) to match the
2D in vivo MRI data. Then, landmarks were manually set using the
resampled ex vivo image and the in vivo pre-contrast T2w image.
The Amira LandmarkWarp module was applied to the native ex
vivo data. The co-registration was refined in AFNI by performing
an affine registration using a least squares cost function. The same
transformations applied to the ex vivo MGE image were applied to
the segmented vessels.
Calculating DTI traces, fiber tracking and visualiza-
tion. Voxel-wise ADC and FA maps were computed from the
DWI data for each brain using DTIStudio (http://www.mrstudio.
org). For each voxel, we calculated the eigenvalues of the diffusion
tensor (l1, l2 and l3), from which ADC and FA were computed
according to:
ADC~
l1zl2zl3
3
~l ð3Þ
FA~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
3=2½(l1{l)
2z(l2{l)
2z(l3{l)
2 
l1
2zl2
2zl3
2
s
ð4Þ
Figure 6. Segmentation of the Vasculature from mMRI Data.
Image processing steps involved in the extraction of the 3D vasculature
from the raw GE mMRI data for a 9L tumor (arrow in all panels) bearing
mouse brain: (a) Ex vivo T2*-weighted image corresponding to the 1
st
TE; (b) Blood vessels (red) segmented out using the ‘‘tubeness’’ filter
overlaid on the raw data in (a). (c) Binarized vasculature obtained by
thresholding the tubeness data in (b) followed by removal of isolated
voxels. (d) Volume rendering of the mMRI-derived vasculature, color-
coded by average vessel radius.
doi:10.1371/journal.pone.0022643.g006
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(DTIStudio) [44,45] with a FA threshold 0.2 and fiber angles less
than 40u between two connected pixels. All fiber tract visualization
and rendering of the vasculature was performed using the Neuro
tool box in Amira.
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